• Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Rating of "Buy" from Brokerages

    来源: Buzz FX / 27 1月 2025 04:41:18   America/New_York


    Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Rating of "Buy" from Brokerages Written by MarketBeat January 27, 2025 Share Link copied to clipboard. Shares of Corvus Pharmaceuticals, Inc.
    Read more...
分享